Visual Universitätsmedizin Mainz

Press Releases

1 2 3 4 Nächste >

2018/07/25

A human endogenous Tumor blocker discovered

Scientists of the Mainz University Medical Center have discovered novel properties of a human protein which acts as an inhibitor of virus infections and cancer

2018/07/25

European Heart Journal reports on world`s first “Heart Valve Unit”

Article in renowned cardiology journal highlights the importance of the new treatment setting for people with heart valve problems

2018/07/20

Targeting headaches and tumors with nano-submarines

New method of transporting drugs published in Nature Nanotechnology

2018/07/10

East German past and mental health

German Federal Ministry of Education and Research sponsors Mainz-based joint research project on risk and protective factors arising from life in the GDR to the sum of EUR 3.8 million

2018/07/02

Direct conversion of non-neuronal cells into nerve cells

Researchers of the Mainz University Medical Center publish new findings in the field of neuroregeneration in Nature Neuroscience

2018/06/14

161 genetic factors for myopia identified

Researchers at the Mainz University Medical Center participate in a genetic study investigating the role of light in the development of myopia

2018/06/14

Mainz scientists identify enzyme responsible for vascular damage caused by aircraft noise

New study of the cardiology of the University Medical Center Mainz continues to show that night-time noise is particularly harmful to vessels and brain

2018/06/04

On the search for new approaches to cure lung cancer

Else Kröner-Fresenius-Stiftung sponsors immunological research project being undertaken by Krishnaraj Rajalingam of the Mainz University Medical Center

2018/05/24

German Research Foundation continues funding of the Life Sciences – Life Writing Research Training Group for an additional four and a half years

Second funding period for the Life Sciences – Life Writing: Boundary Experiences of Human Life between Biomedical Explanation and Lived Experience project

2018/05/03

Kickoff of the DynaMORE resilience research project

Researchers plan to develop a personalized computer model designed to help people better manage crises

2018/05/02

Noise brings the heart out of the rhythm

University Medical Center Mainz publishes new results on noise pollution from the Gutenberg Health Study

2018/04/19

Prof. Ugur Sahin receives prestigious European Research Council (ERC) Advanced Grant for personalized cancer vaccines

New research project ' summit ' aims to develop new immunterapeuthischer approaches

2018/04/19

University Medical Center Mainz Opens “Heart Valve Unit”

A New Patient Care Structure for Patients with Valvular Heart Disease

2018/03/05

Potential new approach to the treatment of multiple sclerosis

Researchers at the Mainz University Medical Center have discovered that the EGFL7 protein inhibits the migration of immune cells into the brain

2018/01/22

Quantum chemistry solves the mystery of why there are these 20 amino acids in the genetic code

Publication in PNAS provides an answer to an old and fundamental question of biochemistry

2017/10/27

Method of accelerating the maturation of stem cells to form neurons discovered

Hydrogel can be used as a scaffold for engineering artificial brain tissue and promotes the development of neurons

2017/09/12

Horizon 2020: EUR 1,8 million for Mainz researchers

EU research and innovation framework program will fund three research projects at the Mainz University Medical Center

2017/07/25

New treatment options for non-alcoholic fatty liver disease

Joint research initiative of the Mainz University Medical Center, Johannes Gutenberg University Mainz, and Goethe University Frankfurt

2017/07/18

Consolidation of data sources allows for new research and treatment approaches in medicine

Mainz University Medical Center is part of a digitalization project funded to the amount of some EUR 32 million by the German Federal Ministry of Education and Research

2017/07/05

Nature Publication Reports Favorable Clinical Trial Results of BioNTech's Individualized Cancer Vaccine IVAC® MUTANOME

First-ever clinical study demonstrates personalized RNA-based vaccine using mutant neo-epitopes as antigens activates immune system against individual mutations and exerts anti-cancer activity

1 2 3 4 Nächste >